Project Grant R01HL179904
Award Date 8/25/25
Completion Date 7/31/30
Dollars Obligated $589K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19140, USA
Similar Awards
- This federal Project Grant award of $778,801 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to improve guideline-concordant care and decrease the risk of pneumonia in people with HIV (PWH). The project, titled "Optimizing Medications and Lung Health in People with HIV through Pharmacist-Led Proactive E-Consults (OPTIMIZE LUNG-HIV)", will test whether a pharmacist-driven e-consult intervention increases the uptake of...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program provides $145,419 to the University of Washington to conduct formative research on implementing integrated care for type 2 diabetes, hypertension, and HIV in Mozambique. The research aims to characterize the determinants for effective implementation of this integrated care model within the country's ongoing health systems strengthening efforts....
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Federal Grant Program for Cardiovascular Diseases Research (CFDA 93.837), provides $123,104 to Emory University to conduct research on factors contributing to cardiovascular disease (CVD) comorbidities in persons living with HIV (PWH). The key objectives are to: 1) assess relationships between the metabolome, lipidome, HIV reservoir, and subclinical CVD, analyzing differences by sex; and 2) determine...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $494,283 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Botswana. This grant will fund the development and testing of new strategies to initiate statin therapy among people living with HIV and hypertension in Botswana. The project, titled "Integrating Hypertension and Cardiovascular Disease Care into Existing HIV Service Package in Botswana (INTERCARE)-Statin Sub-Study",...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $798,698 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Duke University to conduct research on cardiac function and proteomic biomarkers in youth with perinatally acquired HIV infection or exposure. The 5-year project, starting in September 2025, aims to identify imaging and proteomic determinants of cardiac dysfunction in this population compared to HIV unexposed youth, and evaluate the effects on...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $285,195 to Brigham & Women's Hospital to refine the process of identifying patients with uncontrolled hypertension and test an intervention for antihypertensive self-titration. The goal is to adapt and implement a strategy where patients can safely and effectively manage their own blood pressure medication dosages in the U.S....
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $763,858 to Brigham & Women's Hospital, a subsidiary of the Partners Healthcare System, to assess the impact of improving cardiovascular disease (CVD) care for adults with diagnosed diabetes in diverse global settings. The project aims to develop a cardiovascular simulation model, PREDICT-DM, and use it to evaluate the clinical impact, costs, and...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $623,433 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Oregon Health & Science University (OHSU) to implement and evaluate the "Community Vital Signs (CVS)" strategy. This 4-year project aims to increase rates of blood pressure screening and connections to care for hypertension in 12 community-based sites and 12 healthcare facilities across 12 Nigerian cities. The project leverages...
- This $2,981,544 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund research to assess the impact of asymptomatic cytomegalovirus (CMV) infection on cardiovascular disease risk in people living with HIV. The research team at the University of California, San Francisco (UCSF) will leverage data from a prior clinical trial of the CMV-specific antiviral drug letermovir, as well as a case-cohort...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $185,760 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Oregon Health & Science University (OHSU). The project, titled "Leveraging Informatics to Optimize Cardiovascular Risk Prediction in Women", aims to support the principal investigator in developing skills in informatics, epidemiology, and preventive cardiology to advance cardiovascular disease (CVD) risk assessment for women. The...